Emergency Department: Winning in Every ACS Patient Starts Here

omegakimia@yahoo.com
Posted in Drug Talk

On 29 April 2026, I had the privilege of conducting an educational session for the Emergency Department team at KPJ Johor Specialist Hospital, focusing on the management of Acute Coronary Syndrome (ACS) and the critical role of early decision-making in improving patient outcomes.

The session, sponsored by AstraZeneca, highlighted a simple but important message:

The journey to saving a heart begins in the Emergency Department.

Every minute counts when a patient presents with chest pain. The decisions made during the first few hours can significantly influence survival, preservation of heart muscle, and long-term cardiovascular outcomes.

Why the Emergency Department Matters

The Emergency Department serves as the frontline in the battle against cardiovascular disease. For patients presenting with ACS, timely recognition and evidence-based treatment can mean the difference between recovery and devastating complications.

Key objectives discussed during the session included:

  • Rapid identification of ACS patients
  • Early ECG interpretation
  • Appropriate risk stratification
  • Prompt initiation of antiplatelet therapy
  • Early activation of reperfusion pathways for STEMI patients
  • Efficient referral and collaboration with the cardiology team

Recognising High-Risk ACS Patients

Emergency physicians frequently encounter patients with atypical symptoms. While classic crushing chest pain remains a hallmark presentation, clinicians must also maintain a high index of suspicion for:

  • Shortness of breath
  • Epigastric discomfort
  • Diaphoresis
  • Unexplained fatigue
  • Syncope
  • Atypical presentations in women, elderly patients, and diabetics

Early recognition remains the cornerstone of successful management.

Emergency Department

The Importance of Early Dual Antiplatelet Therapy

One of the key discussions centred around platelet inhibition in ACS.

Platelet activation and thrombus formation are central mechanisms responsible for coronary artery occlusion. Early initiation of dual antiplatelet therapy (DAPT), when appropriate, helps reduce recurrent ischaemic events and stent thrombosis following coronary intervention.

The session reviewed current evidence and guideline recommendations regarding:

  • Aspirin administration
  • P2Y12 inhibitor selection
  • Timing of therapy initiation
  • Balancing ischaemic and bleeding risks

Particular attention was given to ensuring that treatment decisions are individualised according to patient characteristics and clinical presentation.

Time is Muscle

The concept of “Time is Muscle” remains as relevant today as ever.

For STEMI patients:

✅ Door-to-ECG within 10 minutes
✅ Rapid diagnosis
✅ Early activation of the catheterisation laboratory
✅ Minimising door-to-balloon time

Every delay results in greater myocardial injury and worse long-term outcomes.

Emergency physicians play a pivotal role in ensuring these patients reach definitive treatment as quickly as possible.

Beyond the Acute Event

Successful ACS management does not end after reperfusion.

We also discussed the importance of:

  • High-intensity lipid lowering therapy
  • Secondary prevention strategies
  • Lifestyle modification
  • Cardiac rehabilitation
  • Long-term medication adherence

For patients who undergo coronary stenting, maintaining optimal LDL-C levels and adherence to prescribed antiplatelet therapy remain critical components of preventing recurrent cardiovascular events.

A Collaborative Effort

Improving outcomes in ACS requires seamless teamwork between emergency physicians, nurses, cardiologists, catheterisation laboratory staff, and rehabilitation teams.

I would like to express my sincere appreciation to the Emergency Department doctors and healthcare professionals at KPJ Johor Specialist Hospital for their active participation and engaging discussions throughout the session.

Together, we continue to strengthen our systems of care and ensure that every ACS patient receives the timely, evidence-based treatment they deserve.

Key Take-Home Message

❤️ Winning in every ACS patient starts in the Emergency Department.

Early recognition, rapid risk assessment, timely antiplatelet therapy, and prompt reperfusion remain the foundations of successful ACS care.

Thank you to the Emergency Department team at KPJ Johor Specialist Hospital for your dedication and commitment to delivering exceptional cardiovascular care.

Rotablation balloon uncrossable lesion

omegakimia@yahoo.com
Posted in KPJ Johor

Rotablation!!

“The balloon can’t cross…” 😳❤️

Not all heart blockages are soft.

Some are rock hard with calcium — so severe that even balloons and stents struggle to pass through.

That’s where Rotablation comes in.

A tiny high-speed diamond burr drills through the calcium to open the artery safely. ⚙️🫀

From “impossible lesion” → successful stenting.

Advanced heart disease needs advanced solutions.

rotablation

_________________________________________________________

“气球都过不去…” 😳❤️

并不是所有心脏血管阻塞都那么简单。

有些血管因为严重钙化，硬得像石头，连气球和支架都无法顺利通过。

这时候，**Rotablation（旋磨术）**就派上用场了。

利用高速旋转的“钻石磨头”，把坚硬钙化慢慢磨开，让血管重新打通。 ⚙️🫀

从“无法处理的病变” → 成功植入支架。

复杂的心脏问题，需要更先进的治疗方案。

This is a case I recently did. Patient was referred from another hospital for balloon uncrossable lesion.

IVUS could not cross & hence Rotablation was done.

Repeated IVUS showed calcium nodule & hence Wolverine & IVL was used

Lesion managed to open nicely after multiple lesion preparation!

From Batam to Survival: A Life-Saving Angioplasty for Acute Heart Attack

omegakimia@yahoo.com
Posted in Misc

Sejujurnya, kisah seperti ini bukan sekadar “kes berhasil”—ini adalah pengingat betapa tipisnya batas antara waktu dan nyawa. Kisah dari Batam.

Seorang pasien datang jauh dari Batam, menyeberangi laut dalam kondisi nyeri dada yang semakin memberat. Saat tiba, gejala yang dialaminya sangat khas untuk serangan jantung akut atau Infark Miokard Akut—suatu kondisi di mana aliran darah ke otot jantung terhenti secara tiba-tiba akibat sumbatan pembuluh darah koroner.

Batam

Dalam situasi seperti ini, waktu bukan lagi sekadar angka di jam. Setiap menit berarti jaringan jantung yang bisa diselamatkan—atau hilang selamanya.

Setelah penilaian awal dan konfirmasi diagnosis, kami segera membawa pasien ke cath lab untuk melakukan Angioplasti Koroner. Prosedur ini bertujuan membuka pembuluh darah yang tersumbat menggunakan balon kecil, diikuti dengan pemasangan Stent Koroner untuk memastikan aliran darah tetap lancar.

Prosesnya berjalan dengan fokus dan koordinasi tinggi. Dalam kondisi darurat seperti ini, setiap langkah harus cepat, tepat, dan terkoordinasi dengan baik. Tim cath lab, perawat, hingga dokter semuanya bergerak sebagai satu kesatuan.

Syukurlah, pembuluh darah yang tersumbat berhasil dibuka, dan aliran darah ke jantung kembali normal.

Namun, yang paling berkesan bukan hanya keberhasilan prosedurnya.

Hari berikutnya, saat melakukan review di wad, kami melihat pasien sudah bisa duduk, berbicara, dan—yang paling penting—tersenyum bersama keluarganya. Wajah yang sebelumnya penuh kecemasan kini berubah menjadi lega dan penuh harapan.

Perjalanan dari Batam bukanlah hal yang mudah, apalagi dalam kondisi darurat. Tapi keputusan untuk segera mencari pertolongan medis terbukti menyelamatkan nyawanya.

Kisah ini kembali menegaskan satu hal penting:
jangan pernah menunda saat muncul gejala serangan jantung.

Nyeri dada, rasa tertekan di dada, menjalar ke lengan atau rahang, sesak napas, atau keringat dingin—semuanya adalah tanda bahaya yang tidak boleh diabaikan. Semakin cepat tindakan dilakukan, semakin besar peluang untuk menyelamatkan otot jantung dan kualitas hidup pasien ke depannya.

Bagi kami sebagai dokter, momen melihat pasien pulih dan kembali ke keluarganya adalah kepuasan yang tidak bisa diukur dengan apapun.

Karena pada akhirnya, ini bukan hanya tentang prosedur atau teknologi.
Ini tentang manusia, tentang keluarga, dan tentang kesempatan kedua dalam hidup.

A Meaningful Journey at ACC Asia 2026 – Gyeongju, Korea

omegakimia@yahoo.com
Posted in Conference, Slider

My recent trip to ACC Asia 2026 in the historic city of Gyeongju was both professionally enriching and personally memorable. Known as “the museum without walls,” Gyeongju provided the perfect backdrop for a gathering of cardiology minds across the region.

ACC Asia

A Proud Professional Milestone

One of the most significant highlights of this trip was being conferred the Fellow of the American College of Cardiology (FACC) during the convocation ceremony. Receiving this recognition from the American College of Cardiology is a meaningful milestone in my journey as a cardiologist. It represents not just years of clinical practice, but also a continued commitment to advancing cardiovascular care and improving patient outcomes.

Standing among respected peers and mentors, the moment was both humbling and motivating—a reminder of the responsibility we carry in shaping the future of cardiology.

Exploring the Timeless Beauty of Gyeongju

Beyond the conference halls, I had the opportunity to explore some of Korea’s most iconic historical landmarks:

  • The serene Bulguksa Temple, a UNESCO World Heritage site, offered a glimpse into Korea’s rich Buddhist heritage and architectural brilliance.
  • The ancient Cheomseongdae Observatory, one of the oldest surviving observatories in Asia, stood as a testament to early scientific advancement.
  • The Daereungwon Tomb Complex, with its rolling burial mounds, reflected the grandeur of the Silla dynasty.

Walking through these sites felt like stepping back in time—an inspiring contrast to the modern innovations discussed during the conference.

A Vibrant Stop in Busan

The journey continued to Busan, South Korea’s dynamic coastal city, where culture meets scenic beauty:

  • The colorful hillside houses of Gamcheon Culture Village created a lively and artistic atmosphere.
  • A ride on the Songdo Marine Cable Car offered breathtaking panoramic views of the coastline.
  • And of course, the iconic Haeundae Beach provided a perfect moment of relaxation by the sea.

Reflections

This trip was more than just a conference—it was a journey of growth, recognition, and cultural appreciation. From meaningful academic exchanges at ACC Asia 2026 to the honor of receiving FACC, and the unforgettable experiences across Gyeongju and Busan, every moment added depth to both my professional and personal journey.

Grateful for the experience, and looking forward to continuing this path of learning, service, and excellence in cardiology.

Grateful for the experience for Singapore Airlines Business class!!

Sandoz JB GP Forum 2026: Are You in Control of Your Cholesterol?

omegakimia@yahoo.com
Posted in Drug Talk

On 21st April 2026, I had the privilege of speaking at the Sandoz JB GP Forum held at Novotel Johor Bahru City Centre. The event brought together general practitioners and healthcare professionals from across Johor for an evening of practical, case-based discussions aimed at improving primary care management.

Sandoz JB GP

My Session: Cholesterol Control in Real-World Practice

My talk, titled:

“Are You in Control of Your Cholesterol? Goals & Management of Hyperdyslipidemia”

focused on one of the most critical yet often underestimated cardiovascular risk factors — cholesterol.

We explored:

  • The importance of early detection and risk stratification
  • Updated LDL-C targets based on cardiovascular risk
  • Common gaps in achieving lipid goals in daily practice
  • Practical strategies to optimize treatment, including when to intensify therapy
  • The role of patient adherence and long-term follow-up

One key takeaway is simple but powerful:
👉 Many patients are treated, but not treated to target.

Bridging the Gap in Primary Care

Primary care plays a central role in preventing heart attacks and strokes. However, despite clear guidelines, a significant number of patients remain above their recommended LDL levels.

During the session, we discussed:

  • When lifestyle measures are not enough
  • When to escalate therapy beyond statins
  • How to individualize treatment without overcomplicating care

The goal is not just prescribing medication — but achieving outcomes.

Engaging Discussions & Collaboration

The session was followed by an interactive Q&A, where we had insightful discussions on real-world challenges faced by GPs — from patient compliance to medication accessibility.

It was encouraging to see such active participation and shared commitment toward improving cardiovascular care in the community.

Gratitude

I would like to thank Sandoz Malaysia for organizing this meaningful forum, and all the attendees for their engagement and thoughtful questions.

Final Thought

Cardiovascular disease remains the leading cause of death, but it is also one of the most preventable.

Control the cholesterol — control the risk.

难忘的一晚: Primary PCI

omegakimia@yahoo.com
Posted in Misc

Primary PCI

那天半夜，急诊部门的一通电话把我从睡梦中惊醒—— 一位病人突发严重心脏病！

我立刻赶往医院。抵达时，病人的儿子焦急地告诉我，他的母亲在车上已经没有反应了……

当我看到她的心跳高达160次/分钟，我知道情况非常危急。我如实告诉他风险极高，而当时其他兄弟姐妹都在新加坡，所有决定只能由他一人承担。

那一刻，他的无助与挣扎，让人心疼。

primary PCI

在时间紧迫、生死一线之间，我们决定立即进行紧急冠状动脉介入治疗（Primary Angioplasty）。手术中成功打通了一条阻塞的血管，并将她送入加护病房继续观察。

然而，挑战才刚开始。在ICU里，我们发现她合并糖尿病酮症酸中毒（DKA），必须紧急处理。同时为她置入中心静脉导管与动脉导管，以进行更严密的监测与治疗。

随后，她又出现了克雷伯氏肺炎杆菌（Klebsiella pneumoniae）菌血症，不得不延长住院时间，接受抗生素治疗。

一关接一关，但她始终坚强地走过来了。

直到今天，她完全康复，带着笑容顺利出院。

临走前，她对我说：“您是我的救命恩人!!” 还送了我一束花表达她的感激之情。

那一刻，我深深感受到——

作为一名医生，最珍贵的礼物，从来不是物质上的回馈，而是看到病人重获新生，带着笑容回家的那一刻。

这，才是我们最大的成就与幸福!!

慢性完全冠状动脉阻塞 CTO：一定需要做心脏搭桥手术吗?

omegakimia@yahoo.com
Posted in KPJ Johor

CTO

当患者进行心脏血管造影检查时，有时会被告知其中一条心脏血管出现 慢性完全冠状动脉阻塞（Chronic Total Occlusion，简称 CTO）。

许多患者听到“完全堵塞”时都会非常担心，甚至认为唯一的治疗方法就是心脏搭桥手术。

事实上，随着现代心脏介入技术的进步，并非所有 CTO 都需要进行搭桥手术。对于部分患者来说，**冠状动脉介入治疗（CTO PCI，俗称心脏支架手术）**也可能是一种有效且较微创的治疗选择。

了解不同治疗方式，有助于患者做出更适合自己的医疗决定。

什么是慢性完全冠状动脉阻塞（CTO）？

CTO 指的是 冠状动脉完全堵塞超过3个月 的情况。

这种阻塞通常是由于：

  • 胆固醇斑块堆积
  • 血管钙化
  • 血管内纤维组织增生

由于阻塞通常是逐渐形成的，人体有时会形成侧支循环（collateral vessels），帮助部分血液绕过堵塞处继续供应心脏。

但很多患者仍可能出现以下症状：

• 胸口疼痛或压迫感（心绞痛）
• 活动时气喘
• 运动耐力下降
• 容易疲劳

有些患者即使症状不明显，心脏供血仍可能受到影响。

CTO

传统治疗：心脏搭桥手术

过去，当发现心脏血管完全堵塞时，医生往往建议进行心脏搭桥手术（CABG）。

这种手术是利用身体其他部位的血管，在堵塞处建立一条新的血流通道，让血液绕过堵塞的血管。

搭桥手术对许多患者来说是一种非常有效的治疗方式，但它属于大型手术，通常需要：

  • 开胸手术
  • 全身麻醉
  • 数天住院时间
  • 数周恢复期

对于部分患者来说，可能因为年龄、其他疾病或个人因素而不适合进行手术。

另一种选择：慢性完全冠状动脉阻塞 CTO 血管介入治疗（CTO PCI）

随着技术进步，现在许多 CTO 也可以通过心脏血管介入治疗来打开血管。

在 CTO PCI 手术中，医生会：

  1. 从手腕或腹股沟血管放入导管
  2. 使用特殊导丝穿过堵塞的血管
  3. 用气球扩张血管
  4. 放置支架保持血管畅通

在经验丰富的中心，CTO PCI 的成功率可以达到 85–90% 以上。

给患者的重要讯息

如果您被诊断为 慢性完全冠状动脉阻塞（CTO）：

这并不一定代表必须进行搭桥手术。

在合适的情况下，CTO 介入治疗也可能是一种有效且较微创的选择。

建议患者与专业心脏科医生讨论，了解最适合自己的治疗方案。

心脏专科咨询

如果您或家人被诊断为冠状动脉阻塞，可以咨询：

林威隽医生 Dr Lim Wei Juan
心脏专科医生（Consultant Cardiologist）
KPJ Johor Specialist Hospital

早期评估和治疗，有助于保护心脏功能并改善生活质量。